4j3d: Difference between revisions
No edit summary |
No edit summary |
||
Line 19: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 4j3d" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 4j3d" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 09:36, 7 February 2018
Pseudomonas aeruginosa LpxC in complex with a hydroxamate inhibitorPseudomonas aeruginosa LpxC in complex with a hydroxamate inhibitor
Structural highlights
Function[LPXC_PSEAE] Involved in the biosynthesis of lipid A, a phosphorylated glycolipid that anchors the lipopolysaccharide to the outer membrane of the cell. Publication Abstract from PubMedLipopolysaccharide (LPS) biosynthesis is an attractive antibacterial target as it is both conserved and essential for the survival of key pathogenic bacteria. Lipid A is the hydrophobic anchor for LPS and a key structural component of the outer membrane of Gram-negative bacteria. Lipid A biosynthesis is performed in part by a unique zinc dependent metalloamidase, LpxC (UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase), which catalyzes the first non-reversible step in lipid A biosynthesis. The UDP portion of the LpxC substrate-binding pocket has been relatively unexplored. We have designed and evaluated a series of hydroxamate based inhibitors which explore the SAR of substitutions directed into the UDP pocket with a range of substituted alpha-amino acid based linkers. We also provide the first wild type structure of Pseudomonas aeruginosa LpxC which was utilized in the design of many of these analogs. Exploring the UDP pocket of LpxC through amino acid analogs.,Hale MR, Hill P, Lahiri S, Miller MD, Ross P, Alm R, Gao N, Kutschke A, Johnstone M, Prince B, Thresher J, Yang W Bioorg Med Chem Lett. 2013 Apr 15;23(8):2362-7. doi: 10.1016/j.bmcl.2013.02.055. , Epub 2013 Mar 1. PMID:23499237[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. References
|
|